"","Num","POD","SD","%","Genes","KE"
"GO:0016209","1","2.35e-06",NA,"9.09","406736","OXIDATION GLUTATHIONE"
"NRF2 PATHWAY","1","2.35e-06",NA,"2.5","406736","ACTIVATION NRF2"
"G GLUTATHIONE METABOLISM","1","2.35e-06",NA,"12.5","406736","DEPLETION GSH"
"GO:0004364","2","2.54676265089623e-06","0.0246926000611551","40","406736, 563972","DOWN REGULATION GSS AND GSTS GENE"
"GLUTATHIONE METABOLIC PROCESS","1","2.76e-06",NA,"10","563972","GLUTATHIONE SYNTHESIS; GLUTATHIONE HOMEOSTASIS"
"GO:0008283","1","3.74e-06",NA,"11.11","30228","PROLIFERATION CELL PROLIFERATION IN THE ABSENCE OF CYTOTOXICITY; ACTIVATION/PROLIFERATION T-CELLS; ALTERATIONS CELLULAR PROLIFERATION / HYPERPLASIA; INCREASE PROLIFERATION LEYDIG CELL; INCREASE MITOGENIC CELL PROLIFERATION HEPATOCYTES; INCREASE HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL; INCREASE REGENERATIVE CELL PROLIFERATION CORNEAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION FORESTOMACH EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION HEPATOCYTES; INCREASE REGENERATIVE CELL PROLIFERATION UROTHELIAL CELLS; INCREASE CELL PROLIFERATION; INCREASE PROLIFERATION OF GOBLET CELLS; INCREASED HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL; PROLIFERATION/CLONAL EXPANSION SMOOTH MUSCLE; INCREASED CELLULAR PROLIFERATION / HYPERPLASIA OF ACINAR CELLS; PROLIFERATION/CLONAL EXPANSION ABERRANT BASAL CELLS; INCREASED CELL PROLIFERATION MESOTHELIUM; INCREASE CELL PROLIFERATION EPITHELIAL CELLS"
"GO:0006635","1","7.23e-06",NA,"5","558088","DECREASED PEROXISOMAL FATTY ACID BETA OXIDATION OF FATTY ACIDS; DECREASED MITOCHONDRIAL FATTY ACID BETA OXIDATION; DECREASED MITOCHONDRIAL FATTY ACID BETA-OXIDATION; INHIBITION MITOCHONDRIAL FATTY ACID BETA-OXIDATION"
"GO:0015908","1","7.23e-06",NA,"4.55","558088","INCREASED FA INFLUX"
"RENAL TUBULAR DYSFUNCTION","1","7.23e-06",NA,"3.85","558088","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"TRIGLYCERIDE METABOLIC PROCESS","1","7.23e-06",NA,"6.25","558088","ACCUMULATION TRIGLYCERIDE"
"GO:0046903","2","7.8485412657385e-05","0.732315596661533","0.87","558088, 335817","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0006936","1","0.000179",NA,"1.82","58082","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"ABNORMAL LIVER MORPHOLOGY","2","0.000230835655824658","1.06360498534481","1.68","558088, 394190","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"ABNORMALITY OF THE LIVER","2","0.000230835655824658","1.06360498534481","0.27","558088, 394190","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"LIPID ACCUMULATION IN HEPATOCYTES","2","0.000230835655824658","1.06360498534481","6.25","558088, 394190","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"GO:1903008","1","0.000268",NA,"7.69","394111","DISRUPTION LYSOSOME"
"ABNORMALITY OF THE ABDOMINAL ORGANS","3","0.000352070709634885","0.51243834315889","1.78","558088, 336998, 394190","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"GO:0007059","3","0.000387980305975982","0.49770698328223","6.82","768140, 317763, 445392","INCREASED CHROMOSOME MISSEGGREGATION"
"UPPER MOTOR NEURON DYSFUNCTION","3","0.000389621506559718","0.518283662753918","0.63","558088, 393528, 394190","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"G OOCYTE MEIOSIS","3","0.000443141382345618","0.51422533677444","7.5","768140, 445392, 399487","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"GO:0006281","1","0.000819",NA,"1.18","336998","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"ABNORMAL LACTATE DEHYDROGENASE LEVEL","1","0.000819",NA,"11.11","336998","DOWN REGULATION GULCOSE-6-PHOSPHATE DEHYDROGENASE"
"ABNORMALITY OF THE OVARY","1","0.000819",NA,"1.75","336998","REDUCED PROSTAGLANDINS OVARY"
"INCREASED SUSCEPTIBILITY TO FRACTURES","1","0.000819",NA,"2.86","336998","INCREASED DISEASE SUSCEPTIBILITY"
"MALE REPRODUCTIVE SYSTEM NEOPLASM","1","0.000819",NA,"6.67","336998","MALFORMATION MALE REPRODUCTIVE TRACT; INDUCTION MALE REPRODUCTIVE TRACT; MALFORMED MALE REPRODUCTIVE TRACT"
"SOMATIC MUTATION","1","0.000819",NA,"1.19","336998","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"GO:0001775","1","0.000852",NA,"0.51","335817","ACTIVATION DENDRITIC CELLS"
"GO:0009611","1","0.000852",NA,"0.89","335817","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0042060","1","0.000852",NA,"1.14","335817","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"PYRUVATE METABOLIC PROCESS","1","0.000852",NA,"1.79","335817","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"GLYCOLYSIS AND GLUCONEOGENESIS","1","0.000852",NA,"4.35","335817","DECREASED PCK1 EXPRESSION CONTROL POINT FOR GLYCOLYSIS/GLUCONEOGENESIS PATHWAY"
"GO:0006633","1","0.00111",NA,"3.45","393528","SYNTHESIS DE NOVO FA; INCREASED DE NOVO FA SYNTHESIS; INCREASED DE NOVO FA SYNTHESIS"
"GO:0006954","1","0.00111",NA,"0.85","393528","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:0006839","3","0.00116250637711844","0.667123113566286","6.52","558088, 399487, 323361","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA"
"GO:0007568","2","0.00161128209820627","0.207809971596874","2.33","336998, 445392","ACCELERATED AGING"
"GO:0015631","1","0.0017",NA,"5.26","567253","BINDING TUBULIN"
"GO:0045444","1","0.0017",NA,"2.44","567253","INCREASED ADIPOGENESIS"
"DNA DAMAGE RESPONSE","2","0.00175015999268638","0.233199467884204","3.45","336998, 399487","INCREASED DNA DAMAGE-REPAIR"
"GO:0007051","3","0.00186783694720726","0.104733697481427","11.11","336998, 317763, 445392","DISORGANIZATION SPINDLE"
"GO:0003824","3","0.00191019052767098","0.170355894252507","4.62","335817, 393528, 394190","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"GO:0006629","7","0.00197053417555575","0.33054449648723","3.4","406736, 558088, 445327, 393528, 394190, 751785, 116517","ALTERATION LIPID METABOLISM"
"GO:0030163","4","0.00247529156849364","0.559902786146499","2.61","768140, 336998, 445392, 403063","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"GO:0022414","2","0.00282076230831313","0.0358452016845976","5.56","317763, 445392","INCREASED REPRODUCTIVE SUCCESS"
"GO:0044703","2","0.00282076230831313","0.0358452016845976","1.72","317763, 445392","N/A REPRODUCTIVE FAILURE"
"GO:0040011","1","0.00317",NA,"0.44","445392","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0048469","1","0.00317",NA,"4.17","445392","INCREASED OOCYTE MATURATION"
"GO:0048870","1","0.00317",NA,"0.5","445392","INCREASED MOTILITY"
"MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION","1","0.00317",NA,"10","445392","DEPOLYMERIZATION MICROTUBULE"
"GO:0019904","1","0.00374",NA,"0.81","399487","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0050673","1","0.00374",NA,"1.22","399487","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"CTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA","1","0.00374",NA,"9.09","399487","DIRECT MITOCHONDRIAL INHIBITION; MITOCHONDRIAL IMPAIRMENT"
"CTOME FOXO MEDIATED TRANSCRIPTION","1","0.00374",NA,"3.57","399487","ACTIVATION FOXO"
"GO:0072358","2","0.00467935893045191","0.523079953384819","1.8","335817, 567941","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"GO:0000003","3","0.00589144782200476","0.185440156180667","1.48","317763, 445392, 567941","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0003714","2","0.00660984114786429","0.417010638751692","10","567253, 567941","STABILIZATION PPAR ALPHA CO-REPRESSOR"
"SYNTHESIS AND DEGRADATION OF KETONE BODIES","1","0.00737",NA,"16.67","394190","NOT INCREASED CIRCULATING KETONE BODIES"
"ABNORMAL CIRCULATING FATTY ACID CONCENTRATION","1","0.00737",NA,"11.11","394190","ACCUMULATION FATTY ACID"
"CHOLESTASIS","1","0.00737",NA,"2.86","394190","INCREASED CHOLESTASIS; CHOLESTASIS PATHOLOGY"
"DECREASED PLASMA CARNITINE","1","0.00737",NA,"14.29","394190","REDUCTION PLASMA VITELLOGENIN CONCENTRATIONS; INCREASE PLASMA VITELLOGENIN CONCENTRATIONS; DECREASED RENAL PLASMA FLOW; INCREASED PLASMA TYROSINE; DECREASED PROSTAGLANDIN F2ALPHA CONCENTRATION PLASMA"
"MORTALITY AGING","1","0.00737",NA,"3.85","394190","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"CTOME SYNTHESIS OF KETONE BODIES","1","0.00737",NA,"12.5","394190","DECREASED KETOGENESIS PRODUCTION OF KETONE BODIES; DECREASED KETOGENESIS"
"ABNORMALITY OF THE MITOCHONDRION","1","0.00737",NA,"0.79","394190","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"INCREASED LEVEL OF HIPPURIC ACID IN URINE","1","0.00737",NA,"33.33","394190","INCREASED BLOOD URIC ACID CONCENTRATION"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","4","0.00776831052779378","0.413537890440978","0.99","445327, 336998, 394190, 777635","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"GO:0009790","4","0.00988724343920442","0.406897514617427","2.37","394111, 393528, 567941, 751785","DEFECT OF EMBRYOGENESIS"
"GO:0010468","1","0.0114",NA,"6.25","30681","DECREASED TRANSCRIPTION OF GENES BY AR"
"GO:0005488","21","0.0114273774053193","0.0841504362622399","1.95","30228, 768140, 58082, 394111, 336998, 335817, 393528, 567253, 317763, 445392, 30681, 567941, 324256, 323361, 406650, 30716, 553788, 777635, 116517, 58099, 403063","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"GO:0006120","1","0.013",NA,"3.7","541328","BINDING OF INHIBITOR NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"GO:0045333","1","0.013",NA,"1.39","541328","INCREASE OXIDATIVE METABOLISM"
"GO:0042701","4","0.0186314274017828","0.617011120948787","11.76","768140, 30681, 30716, 403063","DECREASED PROGESTERONE FROM CORPUS LUTEUM"
"DECREASED BODY WEIGHT","4","0.0236940198156379","0.33505965132569","1.77","336998, 394190, 324256, 553788","DECREASED BODY WEIGHT"
"REGULATION OF CELL DEATH","5","0.0263995262225996","0.327543734152384","1.87","336998, 567253, 399487, 751785, 403063","N/A CELL INJURY/DEATH"
"GO:0016310","7","0.0320948294252722","0.218099914391961","5.6","336998, 335817, 317763, 30681, 30716, 553788, 403063","ACTIVATION SP1"
"POSITIVE REGULATION OF GENE EXPRESSION","2","0.0322403473926693","1.11578629984721","1.1","335817, 553788","ALTERED GENE EXPRESSION"
"ABNORMAL LUNG MORPHOLOGY","3","0.0389826589572514","0.552557942608559","2.34","336998, 324256, 777635","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"GO:0046562","2","0.0398085417969561","1.18054070413812","7.41","335817, 116517","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"REGULATION OF PROTEOLYSIS","2","0.0858358899295627","0.962229007121877","1.79","399487, 403063","IMPAIRED PROTEOSTASIS"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","4","0.0922026814651516","0.386574948061045","2.72","336998, 324256, 553788, 777635","INCREASED RESPIRATORY DISTRESS/ARREST"
"GO:0046983","7","0.102078383999165","0.219604725477001","3.55","336998, 317763, 394190, 751785, 777635, 116517, 58099","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"PEPTIDYL LYSINE MODIFICATION","3","0.131782124508907","0.599330596637218","4.23","393528, 553788, 777635","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"ELECTRON TRANSPORT CHAIN","2","0.155499196139401","0.762108937879922","2.94","541328, 116517","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0005515","2","0.223289050336106","0.663926812951719","4.26","567941, 58099","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"ABNORMAL NASAL MORPHOLOGY","3","0.445208487081051","0.294563099231428","1.94","324256, 553788, 777635","INCREASE SITE OF CONTACT NASAL TUMORS"
"GO:0004882","1","0.731",NA,"2.86","30716","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"GO:0001816","1","1.22",NA,"0.83","553788","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0005102","1","1.22",NA,"0.48","553788","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"GO:0007249","1","1.22",NA,"2.33","553788","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"GO:0032623","1","1.22",NA,"20","553788","SUPPRESSION IL-2 AND IL-4 PRODUCTION"
"FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION","1","1.22",NA,"3.85","553788","ACTIVATION FAS; UP REGULATION FAS"
"ABNORMAL FORM OF THE VERTEBRAL BODIES","1","1.22",NA,"3.03","553788","CLONAL EXPANSION/CELL PROLIFERATION TO FORM ALTERED HEPATIC FOCI AHF"
"JNK CASCADE","1","1.22",NA,"4.55","553788","ACTIVATION JNK"
"LOCOMOTORY BEHAVIOR","1","1.25",NA,"1.61","751785","REDUCED SWIMMING SPEED; REDUCED SWIMMING PERFORMANCE"
"ABNORMALITY OF THE BLADDER","2","1.43589693223434","0.0500373061411739","3.85","553788, 777635","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"CYTOPLASMIC RIBOSOMAL PROTEINS","1","1.78",NA,"0.69","393788","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"BLADDER CANCER","1","1.97",NA,"2.38","403063","INCREASE CANCER"
"BREAST CANCER PATHWAY","1","1.97",NA,"0.88","403063","N/A BREAST CANCER"
"ENDOMETRIAL CANCER","1","1.97",NA,"1.47","403063","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
